These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 11986508)
21. The effect of interpersonal psychotherapy and other psychodynamic therapies versus 'treatment as usual' in patients with major depressive disorder. Jakobsen JC; Hansen JL; Simonsen E; Gluud C PLoS One; 2011 Apr; 6(4):e19044. PubMed ID: 21556370 [TBL] [Abstract][Full Text] [Related]
22. Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial. Braconnier A; Le Coent R; Cohen D; J Am Acad Child Adolesc Psychiatry; 2003 Jan; 42(1):22-9. PubMed ID: 12500073 [TBL] [Abstract][Full Text] [Related]
23. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. Lespérance F; Frasure-Smith N; Koszycki D; Laliberté MA; van Zyl LT; Baker B; Swenson JR; Ghatavi K; Abramson BL; Dorian P; Guertin MC; JAMA; 2007 Jan; 297(4):367-79. PubMed ID: 17244833 [TBL] [Abstract][Full Text] [Related]
24. Is there a dose-effect relationship between the number of psychotherapy sessions and improvement of social functioning? Molenaar PJ; Boom Y; Peen J; Schoevers RA; Van R; Dekker JJ Br J Clin Psychol; 2011 Sep; 50(3):268-82. PubMed ID: 21810106 [TBL] [Abstract][Full Text] [Related]
25. Clomipramine treatment for stereotype and related repetitive movement disorders associated with mental retardation. Lewis MH; Bodfish JW; Powell SB; Golden RN Am J Ment Retard; 1995 Nov; 100(3):299-312. PubMed ID: 8554777 [TBL] [Abstract][Full Text] [Related]
26. Intravenous augmentative citalopram versus clomipramine in partial/nonresponder depressed patients: a short-term, low dose, randomized, placebo-controlled study. Altamura AC; Dell'Osso B; Buoli M; Zanoni S; Mundo E J Clin Psychopharmacol; 2008 Aug; 28(4):406-10. PubMed ID: 18626267 [TBL] [Abstract][Full Text] [Related]
27. Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapy. Bellino S; Zizza M; Rinaldi C; Bogetto F Can J Psychiatry; 2007 Nov; 52(11):718-25. PubMed ID: 18399039 [TBL] [Abstract][Full Text] [Related]
28. Evidence base for the molecular underpinnings of psychodynamic psychotherapy. Alfonso CA Psychodyn Psychiatry; 2012 Sep; 40(3):533-5. PubMed ID: 23002708 [No Abstract] [Full Text] [Related]
29. Efficacy of an adjunctive brief psychodynamic psychotherapy to usual inpatient treatment of depression: rationale and design of a randomized controlled trial. Ambresin G; Despland JN; Preisig M; de Roten Y BMC Psychiatry; 2012 Oct; 12():182. PubMed ID: 23110608 [TBL] [Abstract][Full Text] [Related]
30. Incidence and predictors of relapse during continuation treatment of major depression with SSRI, interpersonal psychotherapy, or their combination. Rucci P; Frank E; Calugi S; Miniati M; Benvenuti A; Wallace M; Fagiolini A; Maggi L; Kupfer DJ; Cassano GB Depress Anxiety; 2011 Nov; 28(11):955-62. PubMed ID: 21898715 [TBL] [Abstract][Full Text] [Related]
31. [Efficacy and tolerability of clomipramine, pirlindole and escitalopram in the treatment of neurotic level depression]. Bun'kova KM Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):29-32. PubMed ID: 18427538 [TBL] [Abstract][Full Text] [Related]
32. Psychotherapy for chronic major depression and dysthymia: a meta-analysis. Cuijpers P; van Straten A; Schuurmans J; van Oppen P; Hollon SD; Andersson G Clin Psychol Rev; 2010 Feb; 30(1):51-62. PubMed ID: 19781837 [TBL] [Abstract][Full Text] [Related]
33. Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy? Dombrovski AY; Cyranowski JM; Mulsant BH; Houck PR; Buysse DJ; Andreescu C; Thase ME; Mallinger AG; Frank E Depress Anxiety; 2008; 25(12):1060-6. PubMed ID: 18781665 [TBL] [Abstract][Full Text] [Related]
34. The risk/benefit ratio of psychiatric treatment. Oldham J J Psychiatr Pract; 2005 May; 11(3):137. PubMed ID: 15920387 [No Abstract] [Full Text] [Related]
35. Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study. Ottevanger EA Encephale; 1995; 21(4):317-21. PubMed ID: 7588171 [TBL] [Abstract][Full Text] [Related]
36. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Hollander E; Allen A; Kwon J; Aronowitz B; Schmeidler J; Wong C; Simeon D Arch Gen Psychiatry; 1999 Nov; 56(11):1033-9. PubMed ID: 10565503 [TBL] [Abstract][Full Text] [Related]
37. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder. Jakobsen JC Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628 [TBL] [Abstract][Full Text] [Related]
38. Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. Salminen JK; Karlsson H; Hietala J; Kajander J; Aalto S; Markkula J; Rasi-Hakala H; Toikka T Psychother Psychosom; 2008; 77(6):351-7. PubMed ID: 18701831 [TBL] [Abstract][Full Text] [Related]
39. Effects of combined pharmacotherapy and psychotherapy for improving work functioning in major depressive disorder. Lam RW; Parikh SV; Ramasubbu R; Michalak EE; Tam EM; Axler A; Yatham LN; Kennedy SH; Manjunath CV Br J Psychiatry; 2013 Nov; 203(5):358-65. PubMed ID: 24029535 [TBL] [Abstract][Full Text] [Related]